False-Positive Mammography Results Are Common

Share this content:
False-Positive Mammography Results Are Common
False-Positive Mammography Results Are Common

TUESDAY, Jan. 12, 2016 (HealthDay News) -- For women undergoing digital mammography screening, false-positive results are common, especially among younger women and those with risk factors, according to research published online Jan. 12 in the Annals of Internal Medicine.

Heidi D. Nelson, M.D., M.P.H., from the Oregon Health & Science University and Providence Health & Services in Portland, and colleagues conducted an analysis of registry data to examine factors associated with false-positive and false-negative digital mammography results. Data were included for 405,191 women aged 40 to 89 years screened with digital mammography between 2003 and 2011. Within 12 months of screening, 2,963 were diagnosed with invasive cancer or ductal carcinoma in situ.

The researchers found that the highest rates of false-positive results and recommendations for additional imaging were seen for women aged 40 to 49 years (121.2 and 124.9 per 1,000 women, respectively), and the rates decreased with increasing age. There was little variation in the rates of false-negative results (1.0 to 1.5 per 1,000 women) and recommendations for biopsy (15.6 to 17.5 per 1,000 women) by age. No difference was seen in results by time since the last screening. Women with risk factors had higher false-positive results, particularly family history of breast cancer, previous benign breast biopsy result, high breast density, and low body mass index for younger women.

"False-positive mammography results and additional imaging are common, particularly for younger women and those with risk factors, whereas biopsies occur less often," the authors write. "Rates of false-negative results are low."

Full Text

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

FDA Permits Marketing of Brain Stimulation Device for OCD

FDA Permits Marketing of Brain Stimulation Device for ...

FDA previously approved transcranial magnetic stimulation for major depression, certain migraines

Comments Open on End of NIH Review for Gene Therapy Studies

Comments Open on End of NIH Review for ...

NIH oversight panel no longer plans to review all applications for gene therapy experiments

U.S. Measles Outbreak Hits 107 Cases in 21 States, D.C.

U.S. Measles Outbreak Hits 107 Cases in 21 ...

Outbreak on track to exceed last year's; most of the people who got measles weren't vaccinated

is free, fast, and customized just for you!




Already a member?

Sign In Now »